Fresh from the sale of their former start-up, device entrepreneurs Chas Taylor and Paul Gilson were contemplating their next venture when they ran into a vascular surgeon of their acquaintance. The surgeon had a particular clinical issue with a widely used device – the inferior vena cava (IVC) filters used to capture blood clots in the bloodstream before they become potentially lethal pulmonary embolisms.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?